Trial Profile
A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir (TDF [tenofovir disoproxil fumarate]) in HIV-HBV co-Infected Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B; HIV infections
- Focus Therapeutic Use
- 22 Apr 2008 New trial record.